Commissioner Human Medicines

Commissioner of the Commission on Human Medicines (CHM)

The closing date is 03 February 2026

The Secretary of State for Health and Social Care is looking to appoint a new Commissioner to the Commission on Human Medicines (CHM). Candidates should be recognised by their peers and/or be Fellows of the relevant Royal Colleges in the following area:
Medical Oncology.

To be considered for this role, please apply via the Apply for Public Appointments website ((Use the "Apply for this Job" box below).). Only applications submitted on that website will be considered.

As a commissioner you will possess or develop a working knowledge and understanding of the UK medicines regulatory procedures. You will draw on your individual expertise and judgement for all agenda items and assist the CHM to provide advice to Ministers. We are looking for skilled communicators who can assimilate complex scientific information at short notice, and take account of a wider view of risk and benefit, particularly as it is perceived by patients, carers and other members of the public.

The Commission on Human Medicines is an Advisory Non‑Departmental Public Body, set up in law to advise UK Health Ministers on the safety, quality and efficacy of medicines for human use and to promote the collection and investigation of adverse drug reactions.

The Medicines and Healthcare products Regulatory Agency (MHRA) seeks independent advice from the CHM to ensure its scientific judgements are robust and informed by clinical practice. It is primarily a multidisciplinary scientific advisory committee comprised of experts from medical, pharmaceutical, and related scientific disciplines and includes lay/patient representatives.

For full details on job description, please refer to advert attached in this vacancy or visit -publi

• Be recognised by peers and/or a Fellow of the relevant Royal College in Medical Oncology.
• Be a skilled communicator, able to operate effectively on a national expert scientific committee and prepared to contribute actively to the work of the CHM.
• Be able to assimilate complex scientific information at short notice.
• Have an understanding of the importance of patient engagement to the work of CHM and MHRA and be able to proactively incorporate patients’ lived experience in committee discussions.

This post is subject to the Rehabilitation of Offenders Act (Exceptions Order) 1975 and will require a submission for Disclosure to the Disclosure and Barring Service.

Medicines and Healthcare Products Regulatory Agency